company background image

Last Price

AU$293.00

Market Cap

AU$142.1b

7D

-1.8%

1Y

12.5%

Updated

30 Jan, 2023

Data

Company Financials +

CSL Stock Overview

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally.

CSL fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 15.24% per year

Risk Analysis

No risks detected for CSL from our risk checks.

My Notes

New

Notes are coming soon

CSL Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CSL
Historical stock prices
Current Share PriceAU$293.00
52 Week HighAU$304.70
52 Week LowAU$240.10
Beta0.18
1 Month Change1.82%
3 Month Change3.44%
1 Year Change12.54%
3 Year Change-5.91%
5 Year Change100.08%
Change since IPO36,525.37%

Recent News & Updates

Recent updates

CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

Nov 17
CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

CSL Limited (ASX:CSL) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 27
CSL Limited (ASX:CSL) Shares Could Be 24% Below Their Intrinsic Value Estimate

We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Aug 19
We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Is CSL Limited (ASX:CSL) Trading At A 22% Discount?

Jul 29
Is CSL Limited (ASX:CSL) Trading At A 22% Discount?

CSL's (ASX:CSL) Problems Go Beyond Weak Profit

Feb 22
CSL's (ASX:CSL) Problems Go Beyond Weak Profit

Is CSL Limited (ASX:CSL) Worth AU$270 Based On Its Intrinsic Value?

Jan 19
Is CSL Limited (ASX:CSL) Worth AU$270 Based On Its Intrinsic Value?

With EPS Growth And More, CSL (ASX:CSL) Is Interesting

Dec 08
With EPS Growth And More, CSL (ASX:CSL) Is Interesting

CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

Oct 26
CSL (ASX:CSL) Seems To Use Debt Quite Sensibly

We Think Shareholders Will Probably Be Generous With CSL Limited's (ASX:CSL) CEO Compensation

Oct 05
We Think Shareholders Will Probably Be Generous With CSL Limited's (ASX:CSL) CEO Compensation

Here's Why We Think CSL (ASX:CSL) Is Well Worth Watching

Sep 02
Here's Why We Think CSL (ASX:CSL) Is Well Worth Watching

CSL Limited (ASX:CSL) Shares Could Be 30% Above Their Intrinsic Value Estimate

Jul 22
CSL Limited (ASX:CSL) Shares Could Be 30% Above Their Intrinsic Value Estimate

CSL (ASX:CSL) Has A Pretty Healthy Balance Sheet

Jul 01
CSL (ASX:CSL) Has A Pretty Healthy Balance Sheet

Do CSL's (ASX:CSL) Earnings Warrant Your Attention?

May 20
Do CSL's (ASX:CSL) Earnings Warrant Your Attention?

We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Mar 29
We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Is Weakness In CSL Limited (ASX:CSL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 08
Is Weakness In CSL Limited (ASX:CSL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

A Look At The Fair Value Of CSL Limited (ASX:CSL)

Feb 19
A Look At The Fair Value Of CSL Limited (ASX:CSL)

Results: CSL Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 19
Results: CSL Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's Why I Think CSL (ASX:CSL) Might Deserve Your Attention Today

Feb 01
Here's Why I Think CSL (ASX:CSL) Might Deserve Your Attention Today

Announcing: CSL (ASX:CSL) Stock Increased An Energizing 152% In The Last Five Years

Jan 14
Announcing: CSL (ASX:CSL) Stock Increased An Energizing 152% In The Last Five Years

Our Take On CSL's (ASX:CSL) CEO Salary

Dec 24
Our Take On CSL's (ASX:CSL) CEO Salary

We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Dec 06
We Think CSL (ASX:CSL) Can Stay On Top Of Its Debt

Is Weakness In CSL Limited (ASX:CSL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Jul 27
Is Weakness In CSL Limited (ASX:CSL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Should You Be Adding CSL (ASX:CSL) To Your Watchlist Today?

Jul 06
Should You Be Adding CSL (ASX:CSL) To Your Watchlist Today?

Shareholder Returns

CSLAU BiotechsAU Market
7D-1.8%-1.4%0.6%
1Y12.5%11.8%3.5%

Return vs Industry: CSL matched the Australian Biotechs industry which returned 11.8% over the past year.

Return vs Market: CSL exceeded the Australian Market which returned 3.5% over the past year.

Price Volatility

Is CSL's price volatile compared to industry and market?
CSL volatility
CSL Average Weekly Movement2.3%
Biotechs Industry Average Movement9.1%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.7%
10% least volatile stocks in AU Market3.5%

Stable Share Price: CSL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: CSL's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
191630,000Paul Perreaulthttps://www.csl.com.au

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants.

CSL Limited Fundamentals Summary

How do CSL's earnings and revenue compare to its market cap?
CSL fundamental statistics
Market CapAU$142.11b
Earnings (TTM)AU$3.17b
Revenue (TTM)AU$14.86b

44.5x

P/E Ratio

9.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CSL income statement (TTM)
RevenueUS$10.56b
Cost of RevenueUS$4.83b
Gross ProfitUS$5.73b
Other ExpensesUS$3.48b
EarningsUS$2.25b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Feb 14, 2023

Earnings per share (EPS)4.68
Gross Margin54.27%
Net Profit Margin21.35%
Debt/Equity Ratio56.7%

How did CSL perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

46%

Payout Ratio